Immunotherapy has emerged as a promising therapy for the treatment of several solid tumors and various immune checkpoint molecules such as PD-1/PD-L1 and CTLA-4 have been found to play an important role in tumor immune escape 41. This evidence concerns the gene CTLA4 and neoplasm.